Semaglutide compounding pharmacies remain a hot topic in 2025 — learn how these pharmacies work, what the FDA allows, and what to ask before you buy.
Semaglutide compounding pharmacies are state-licensed pharmacies that mixed their own versions of the GLP-1 drug semaglutide, usually because brand-name Ozempic, Wegovy, and Rybelsus were in short supply. In 2025, the FDA considers the semaglutide shortage resolved and has told most compounders to stop making copies of the drug, so compounded semaglutide is now far harder to get legally in the United States. What remains is a gray market with real questions about purity, dosing, and legal oversight.
Why Compounding Pharmacies Started Making Semaglutide
Compounding is a normal part of pharmacy practice. A licensed pharmacist may mix a custom medication when an FDA-approved product does not work for a specific patient, such as when someone is allergic to a dye in a tablet.
Semaglutide was different. Between 2022 and 2024, demand for GLP-1 weight-loss drugs exploded and the FDA placed semaglutide on its shortage list. With brand supply stretched thin, compounding pharmacies bought semaglutide API — often semaglutide sodium, a slightly different salt form — mixed it into vials, and sold it through telehealth clinics for roughly $150 to $400 a month.
That window made compounded semaglutide a household name. It also created a market that was never reviewed by the FDA for safety, effectiveness, or manufacturing quality.
What the FDA and the Courts Say Now
Federal law bars compounding an “essentially a copy” of a commercially available, FDA-approved drug. Once the FDA removed semaglutide from the shortage list in early 2025, that rule took effect again.
- 503A pharmacies (traditional compounding) had to stop making copies by April 22, 2025.
- 503B outsourcing facilities had to stop by May 22, 2025.
- A narrow exception allows compounding for an individual patient with a documented clinical need, such as an allergy to an inactive ingredient in the brand product.
Semaglutide compounded by a pharmacy is not FDA-approved for human use in the United States.
Litigation is ongoing, and some pharmacies have kept shipping product while courts weigh the FDA’s timeline. Enforcement has not been uniform, which is why you may still see compounded semaglutide advertised even where it is not clearly permitted.
Compounded vs. Brand-Name Semaglutide
| Feature | Brand-name (Ozempic, Wegovy, Rybelsus) | Compounded semaglutide |
|---|---|---|
| FDA approval | Approved for specific uses | Not approved |
| Active ingredient | Semaglutide base | Often semaglutide sodium |
| Testing | Batch-tested by the manufacturer | Varies; some third-party certificates of analysis |
| Typical monthly cost | $900–$1,400 list before insurance | $150–$400 when available |
| Availability in 2025 and after | Widely available | Restricted and legally limited |
Price is the main reason people sought compounded versions, and it is still the main driver of demand. Price is not evidence of equivalence, though, and the two products are not interchangeable on paper.
Semaglutide Side Effects and Safety Signals
Semaglutide side effects do not change based on who mixed the vial. Common issues include nausea, vomiting, diarrhea, constipation, and belly pain, usually during dose increases.
Serious risks are rarer but real: pancreatitis, gallbladder disease, kidney injury from dehydration, and thyroid C-cell tumors seen in animal studies. Those are reasons to use a prescribed product under medical supervision.
With compounded versions, add manufacturing risk. Independent lab testing has found vials with incorrect concentrations, and the FDA has logged reports of dosing errors tied to multi-dose vials and unfamiliar syringes. Purity and sterility depend entirely on the individual pharmacy.
How to Vet a Semaglutide Compounding Pharmacy
If you are searching for a compounding semaglutide pharmacy near you — or responding to a semaglutide compounding near me ad on social media — start with the basics before you pay.
- Confirm the pharmacy’s state license and whether it operates as a 503A or 503B facility.
- Ask who supplies the active pharmaceutical ingredient and whether that supplier is FDA-registered.
- Request the semaglutide ingredients list and the batch certificate of analysis.
- Check the concentration and dosing instructions against the prescriber’s orders.
- Ask which clinician is prescribing and how follow-up labs and check-ins are handled.
- Be skeptical of any claim that a compounded product is “identical to Ozempic.”
Reddit and social media can help you spot red flags. Reading semaglutide pills reviews reddit threads, for example, shows how wide the range of experiences is — but anecdotes are not evidence of safety or effectiveness.
Research is moving quickly, and studies of combinations such as cagrilintide and semaglutide could shape future treatment options. None of that changes the current regulatory status of compounded semaglutide in the United States.
The Bottom Line for Patients
Compounded semaglutide filled a real gap during a supply crisis, and it helped many people start treatment when nothing else was available. That era has largely ended in the US.
If you already have compounded semaglutide, do not adjust your dose on your own, and do not order from an unverified overseas seller. Talk to a licensed healthcare professional about switching to an FDA-approved product or another option that fits your health and budget.
Regulators abroad have moved in the same direction, tightening rules on compounded GLP-1 drugs and warning about unlicensed online sellers. The safest path is a prescription from a clinician who knows your medical history, filled by a pharmacy you can verify.
Frequently Asked Questions
Is compounded semaglutide still legal in the US?
It is now heavily restricted. After the FDA declared the semaglutide shortage resolved, 503A compounding pharmacies had to stop making copies by April 22, 2025, and 503B outsourcing facilities by May 22, 2025. A pharmacy may still compound semaglutide for an individual patient if a prescriber documents a clinically significant need, such as an allergy to an ingredient in the brand product.
Are compounded and brand-name semaglutide the same thing?
No. Ozempic, Wegovy, and Rybelsus are FDA-approved and made with semaglutide base. Compounded versions were typically made with semaglutide sodium and were never reviewed by the FDA for purity, potency, or sterility, so they are not interchangeable with approved products.
How much did compounded semaglutide cost per month?
Most telehealth programs charged roughly $150 to $400 per month, compared with $900 to $1,400 for brand-name products without insurance. The lower price reflected cheaper ingredients and no FDA review, not proven equivalence to approved semaglutide. Verify current pricing and legality with a licensed pharmacy or prescriber before paying.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.